Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)

[1]  Amir Shabani,et al.  Author response for "Psychometric properties of Structured Clinical Interview for DSM‐5 Disorders‐Clinician Version (SCID‐5‐CV)" , 2020 .

[2]  O. Vranjkovic,et al.  The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis. , 2020, Pharmacogenomics.

[3]  A. Serretti,et al.  Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future , 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[4]  A. Serretti,et al.  Pharmacogenetics and Depression: A Critical Perspective , 2019, Psychiatry investigation.

[5]  B. Dunlop,et al.  Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. , 2019, Pharmacogenomics.

[6]  A. Serretti,et al.  Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  B. Grant,et al.  Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States , 2018, JAMA psychiatry.

[8]  Publisher's Note , 2018, Anaesthesia.

[9]  E. Baca-García,et al.  Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial , 2017, BMC Psychiatry.

[10]  B. DeChairo,et al.  Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility , 2015, The Yale journal of biology and medicine.

[11]  Peter M Visscher,et al.  Large-scale genomics unveils the genetic architecture of psychiatric disorders , 2014, Nature Neuroscience.

[12]  D. Mrazek,et al.  Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting , 2013, Pharmacogenetics and genomics.

[13]  K. Tansey,et al.  Contribution of Common Genetic Variants to Antidepressant Response , 2013, Biological Psychiatry.

[14]  W. Hiller,et al.  Effectiveness of and dropout from outpatient cognitive behavioral therapy for adult unipolar depression: a meta-analysis of nonrandomized effectiveness studies. , 2013, Journal of consulting and clinical psychology.

[15]  M. Isola,et al.  Validation of the Italian version of Mini-ICF-APP, a short instrument for rating activity and participation restrictions in psychiatric disorders , 2012, Epidemiology and Psychiatric Sciences.

[16]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[17]  A. Serretti,et al.  Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression , 2011, Journal of clinical psychopharmacology.

[18]  Jonathan Y. Tsou.  RACHEL COOPER Classifying Madness: A Philosophical Examination of the Diagnostic and Statistical Manual of Mental Disorders , 2010, The British Journal for the Philosophy of Science.

[19]  A. Bifulco,et al.  The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series. , 2005, The British journal of clinical psychology.

[20]  J. Guelfi,et al.  Factorial structure of the 17‐item Hamilton Depression Rating Scale , 1995, Acta psychiatrica Scandinavica.

[21]  U. Ahlfors,et al.  The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.

[22]  S Baratta,et al.  Inter-rater reliability of the Italian version of the Paykel Scale of stressful life events. , 1985, Journal of affective disorders.

[23]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[24]  M. Fava,et al.  The STAR*D study: Treating depression in the real world INTERPRETING KEY TRIALS , 2007 .